0001209191-17-058481.txt : 20171031 0001209191-17-058481.hdr.sgml : 20171031 20171031181806 ACCESSION NUMBER: 0001209191-17-058481 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171031 FILED AS OF DATE: 20171031 DATE AS OF CHANGE: 20171031 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SMITH IAN F CENTRAL INDEX KEY: 0001197032 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 171166873 MAIL ADDRESS: STREET 1: C/O ACORDA THERAPEUTICS, INC. STREET 2: 420 SAW MILL RIVER ROAD CITY: ARDSLEY STATE: NY ZIP: 10502 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-10-31 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001197032 SMITH IAN F C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 0 1 0 0 EVP, COO Common Stock 2017-10-31 4 S 0 1700 142.40 D 114188 D Common Stock 2017-10-31 4 S 0 5200 143.47 D 108988 D Common Stock 2017-10-31 4 S 0 32945 144.47 D 76043 D Common Stock 2017-10-31 4 S 0 22464 145.26 D 53579 D Common Stock 2017-10-31 4 S 0 5200 146.39 D 48379 D Common Stock 2017-10-31 4 S 0 3500 147.40 D 44879 D Common Stock 2017-10-31 4 S 0 3791 148.26 D 41088 D Common Stock 2017-10-31 4 S 0 200 149.34 D 40888 D Common Stock 5306 I 401(k) Transaction made pursuant to Mr. Smith's company-approved trading plan under Rule 10b5-1. Open market sales reported on this line occurred at a weighted average price of $142.40 (range $141.83 to $142.75). Mr. Smith undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $143.47 (range $142.91 to $143.85). Open market sales reported on this line occurred at a weighted average price of $144.47 (range $143.91 to $144.89). Open market sales reported on this line occurred at a weighted average price of $145.26 (range $144.93 to $145.87). Open market sales reported on this line occurred at a weighted average price of $146.39 (range $145.30 to $146.92). Open market sales reported on this line occurred at a weighted average price of $147.40 (range $146.93 to $147.90). Open market sales reported on this line occurred at a weighted average price of $148.26 (range $147.93 to $148.70). /s/ Omar White, Attorney-in-Fact 2017-10-31